Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014

dc.contributor.authorThompson, Craig
dc.contributor.authorDey, Aditi
dc.contributor.authorFearnley, Emily
dc.contributor.authorPolkinghorne, Ben
dc.contributor.authorBeard, Frank
dc.date.accessioned2021-07-08T00:04:27Z
dc.date.issued2017
dc.date.updated2020-11-23T10:39:50Z
dc.description.abstractIn November 2005, hepatitis A vaccine was funded under the Australian National Immunisation Program for Aboriginal and Torres Strait Islander (Indigenous) children aged 12–24 months in the targeted jurisdictions of Queensland, South Australia, Western Australia and the Northern Territory. We reviewed the epidemiology of hepatitis A from 2000 to 2014 using data from the Australian National Notifiable Diseases Surveillance System, the National Hospital Morbidity Database, and Australian Bureau of Statistics causes-of-death data. The impact of the national hepatitis A immunisation program was assessed by comparison of pre-vaccine (2000–2005) and post-vaccine time periods (2006–2014), by age group, Indigenous status and jurisdiction using incidence rate ratios (IRR) per 100,000 population and 95% confidence intervals (CI). The national pre-vaccine notification rate in Indigenous people was four times higher than the non-Indigenous rate, and declined from 8.41 per 100,000 (95% CI 5.03–11.79) pre-vaccine to 0.85 per 100,000 (95% CI 0.00–1.99) post-vaccine, becoming similar to the non-Indigenous rate. Notification and hospitalisation rates in Indigenous children aged <5 years from targeted jurisdictions declined in the post-vaccine period when compared to the pre-vaccine period (notifications: IRR = 0.07; 95% CI 0.04–0.13; hospitalisations: IRR = 0.04; 95% CI 0.01–0.16). As did notification rates in Indigenous people aged 5–19 (IRR = 0.08; 95% CI 0.05–0.13) and 20–49 years (IRR = 0.06; 95% CI 0.02–0.15) in targeted jurisdictions. For non-Indigenous people from targeted jurisdictions, notification rates decreased significantly in children aged <5 years (IRR 0.47; 95% CI 0.31–0.71), and significantly more overall (IRR = 0.43; 95% CI 0.39–0.47) compared to non-Indigenous people from non-targeted jurisdictions (IRR = 0.60; 95% CI 0.56–0.64). The national hepatitis A immunisation program has had a significant impact in the targeted population with relatively modest vaccine coverage, with evidence suggestive of substantial herd protection effects. Keywords Indigenous; Vaccination; Targeted; Epidemiology; Notification; Hepatitis Aen_AU
dc.description.sponsorshipThis work was supported by the National Centre for Immunisation Research and Surveillance. CT is a scholar in the Master of Philosophy in Applied Epidemiology, Australian National University.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0264-410Xen_AU
dc.identifier.urihttp://hdl.handle.net/1885/238609
dc.language.isoen_AUen_AU
dc.publisherElsevieren_AU
dc.rights© 2016 Elsevier Ltd.en_AU
dc.sourceVaccineen_AU
dc.subjectIndigenousen_AU
dc.subjectVaccinationen_AU
dc.subjectTargeteden_AU
dc.subjectEpidemiologyen_AU
dc.subjectNotificationen_AU
dc.subjectHepatitis Aen_AU
dc.titleImpact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014en_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue1en_AU
local.bibliographicCitation.lastpage176en_AU
local.bibliographicCitation.startpage170en_AU
local.contributor.affiliationThompson, Craig, Sydney Children's Hospital Network Westmead NSWen_AU
local.contributor.affiliationDey, Aditi, National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseasesen_AU
local.contributor.affiliationFearnley, Emily, College of Health and Medicine, ANUen_AU
local.contributor.affiliationPolkinghorne, Ben, Commonwealth Department of Healthen_AU
local.contributor.affiliationBeard , Frank, Sydney Children's Hospital Network Westmead NSWen_AU
local.contributor.authoruidFearnley, Emily, u4358267en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor111706 - Epidemiologyen_AU
local.identifier.absfor111716 - Preventive Medicineen_AU
local.identifier.absfor110309 - Infectious Diseasesen_AU
local.identifier.absseo920109 - Infectious Diseasesen_AU
local.identifier.absseo920303 - Aboriginal and Torres Strait Islander Health - Health System Performance (incl. Effectiveness of Interventions)en_AU
local.identifier.absseo920404 - Disease Distribution and Transmission (incl. Surveillance and Response)en_AU
local.identifier.ariespublicationa383154xPUB6258en_AU
local.identifier.citationvolume35en_AU
local.identifier.doi10.1016/j.vaccine.2016.11.002en_AU
local.identifier.scopusID2-s2.0-84999808917
local.identifier.thomsonID000390517900023
local.publisher.urlhttps://www.elsevier.com/en-auen_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Thompson_Impact_of_the_national_2017.pdf
Size:
638.02 KB
Format:
Adobe Portable Document Format
abcd